10 Best Rebound Stocks To Invest In Now

Page 10 of 10

1. Dyne Therapeutics, Inc. (NASDAQ:DYN)

Number of Hedge Fund Holders: 40 

Year-To-Date Decline in Share Price: 34.9%   

Dyne Therapeutics, Inc. (NASDAQ:DYN) is a clinical-stage muscle disease company that operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The firm recently announced that the US Food and Drug Administration had issued a fast-track designation for DYNE-101, an experimental therapy for a rare muscle disorder called myotonic dystrophy type 1 (DM1). Fast-track designation allows for an accelerated timeline in the development and review of drugs targeted at serious conditions with unmet medical needs. The drug is currently undergoing a global Phase 1/2 trial for DM1. Dyne expects to seek the FDA’s accelerated approval for the product in H1 2026.

While we acknowledge the potential of Dyne Therapeutics, Inc. (NASDAQ:DYN) as an investment, our conviction lies in the belief that some stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a stock that is more promising than Dyne Therapeutics, Inc. (NASDAQ:DYN) but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 10 of 10